Shanghai, China

Shi Hu

This inventor holds 7 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Naval Medical University, Pharchoice Therapeutics Inc, Dell Products Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shi Hu. Retrieved from https://idiyas.com/inventor/shi-hu-okhbodla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shi Hu

Introduction

Shi Hu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 7 patents to his name, Shi Hu has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are the "Anti-Tetrodotoxin Antibody K548" and the "Anti-Tetrodotoxin Antibody C31K8," both of which include preparation methods and their uses. These innovations are crucial in advancing medical research and therapeutic applications.

Career Highlights

Shi Hu has worked with notable institutions such as Naval Medical University and Pharchoice Therapeutics Inc. His work in these organizations has allowed him to collaborate on various projects that push the boundaries of scientific knowledge.

Collaborations

Shi Hu has collaborated with several professionals in his field, including Wenyan Fu and Changhai Lei. These partnerships have fostered a productive environment for innovation and research.

Conclusion

Shi Hu's contributions to biotechnology and his impressive portfolio of patents highlight his role as a leading inventor in his field. His work continues to influence advancements in medical science and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…